SMART Trial: Reducing Stigma Towards Opioid Use Disorder at the Community Level

Karen Derefinko, PhD1 site in 1 country199 target enrollmentJune 16, 2021

ConditionsOpioid-use Disorder Stigma, Social

Overview

Phase: Not Applicable
Intervention: Not specified
Conditions: Opioid-use Disorder
Sponsor: Karen Derefinko, PhD
Enrollment: 199
Locations: 1
Primary Endpoint: Stigma score
Status: Completed
Last Updated: 4 years ago

Overview Investigators Eligibility Criteria Outcomes Sites Similar Trials

Overview

Brief Summary

The goal of this project is to engage community members from two low-income African American communities (N=200) in a survey study that assesses stigma toward those with Opioid Use Disorder (OUD). Those from the intervention community will be subject to a stigma reduction campaign via billboards. Those from the control community will not. Stigma will be re-assessed following the period of the campaign.

Registry

clinicaltrials.gov

Start Date

June 16, 2021

End Date

August 19, 2021

Last Updated

4 years ago

Study Type

Interventional

Study Design

Parallel

Sex

All

Investigators

Sponsor

Karen Derefinko, PhD

Responsible Party

Sponsor Investigator

Principal Investigator

Karen Derefinko, PhD

Associate Professor

University of Tennessee

Eligibility Criteria

Inclusion Criteria

•Identify as African American or Mixed race
•Reside in Frayser or Orange Mound Communities
•Access to telephone for follow-up assessment

Exclusion Criteria

•Unable to understand consent procedures

Outcomes

Primary Outcomes

Stigma score

Time Frame: Change from baseline stigma score at 8 weeks

Pre- and post-intervention stigma assessments using the Exposure to Drug Users Index, Drug Use Stigmatization Scale, and the Stigma of Drug Users Scale